Author

Jisook Kim

Institutions: Hanmi Pharmaceutical (South Korea), Sungkyunkwan University

Observed institutions: University of Minnesota, University of Tennessee at Chattanooga, Hanmi Pharmaceutical (South Korea), Sungkyunkwan University

ORCID: 0000-0001-7389-0778

Observed ORCID: 0000-0001-7389-0778

OpenAlex ID: A5102835527

Synthesis and biological evaluation of novel thienopyrimidine derivatives as diacylglycerol acyltransferase 1 (DGAT-1) inhibitors

2019 · Dong Jin Hong, Seung Hyun Jung, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 19

A Method for Quantitating the Intracellular Metabolism of AZT Amino Acid Phosphoramidate Pronucleotides by Capillary High-Performance Liquid Chromatography−Electrospray Ionization Mass Spectrometry

2005 · Jisook Kim, Soobong Park, et al. · Molecular Pharmaceutics · 14

Discovery of novel pyrimidine and malonamide derivatives as TGR5 agonists

2014 · Eun Ju Park, Young Gil Ahn, et al. · Bioorganic & Medicinal Chemistry Letters · 13

Discovery of 2,6-Naphthyridine Analogues as Selective FGFR4 Inhibitors for Hepatocellular Carcinoma

2024 · Heesook Oh, Jisook Kim, et al. · Journal of Medicinal Chemistry · 11

Structure–activity relationship studies of Imidazo[1′,2′:1,6]pyrido[2,3-d]pyrimidine derivatives to develop selective FGFR inhibitors as anticancer agents for FGF19-overexpressed hepatocellular carcinoma

2024 · Jisook Kim, Seung Hyun Jung, et al. · European Journal of Medicinal Chemistry · 9

Biological implications of 2-chlorocyclohexa-2,5-diene-1,4-dione toward ribonuclease A

2013 · Albert R. Vaughn, Caitlin B. Redman, et al. · Advances in Bioscience and Biotechnology · 7

Monitoring the Intracellular Metabolism of Nucleoside Phosphoramidate Pronucleotides by31P NMR

2004 · Jisook Kim, Daniel P. Drontle, et al. · Nucleosides Nucleotides & Nucleic Acids · 5

Abstract 3335: A novel and potent IRE1α RNase inhibitor, HM100168 as a promising therapeutic strategy in solid cancers

2024 · Jisook Kim, Seung Hyun Jung, et al. · Cancer Research · 3

The study of a novel SWRO-PRO hybrid desalination technology

2018 · Jisook Kim, Inho Yeo, et al. · Journal of The Korean Society of Water and Wastewater · 3

Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists

2020 · Inhwan Bae, Daejin Kim, et al. · Bioorganic & Medicinal Chemistry Letters · 2

Abstract 1614: Antitumor activity of novel and potent YAP/TAZ-TEAD inhibitorstargeting the Hippo pathway in solid tumors

2023 · Jisook Kim, Seung Hyun Jung, et al. · Cancer Research · 1

Design, Synthesis, and Biological Evaluation of Imidazopyrazinone Derivatives as Antagonists of Inhibitor of Apoptosis Proteins (IAPs)

2021 · Jisook Kim, Inhwan Bae, et al. · Bulletin of the Korean Chemical Society · 1

Discovery of Reversible Lysine-Specific Demethylase 1 Inhibitors with Pyrazole Core for Small Cell Lung Cancer Treatment

2026 · Jaeyul Choi, Jihun Kim, et al. · Journal of Medicinal Chemistry

Abstract B116: Robust efficacy and favorable safety profile of pan-TEAD inhibitors in oncogenic Hippo pathway-dysregulated cancers including mesothelioma

2025 · Jisook Kim, Chunghoon Shin, et al. · Molecular Cancer Therapeutics

Works count: 14

Citation count: 88

H-index: 6

I10-index: 4